Resveratrol suppresses the epithelial-to-mesenchymal transition in PC-3 cells by down-regulating the PI3K/AKT signaling pathway

Cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Prognostic prostate tissue biomarkers of potential clinical use

(2014) Theodorus H. Van der Kwast   VIRCHOWS ARCHIV

Can we improve the definition of high-risk, hormone naïve, non-metastatic prostate cancer?

(2013) Bertrand Tombal et al.   BJU INTERNATIONAL

Resveratrol Inhibits the Epithelial-Mesenchymal Transition of Pancreatic Cancer Cells Via Suppression of the PI-3K/Akt/NF-κB Pathway

(2013) Wei Li et al.   CURRENT MEDICINAL CHEMISTRY

Perspectives on Immunotherapy in Prostate Cancer and Solid Tumors: Where Is the Future?

(2013) Alexandra Snyder et al.   SEMINARS IN ONCOLOGY

Molecular Diagnosis of Prostate Cancer: Are We Up to Age?

(2013) Tapan Bhavsar et al.   SEMINARS IN ONCOLOGY

The EMT signaling pathways in endometrial carcinoma

(2012) Eva Colas et al.   Clinical & Translational Oncology

Secreted Hsp90 Is a Novel Regulator of the Epithelial to Mesenchymal Transition (EMT) in Prostate Cancer

(2012) Michael W. Hance et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Resveratrol downregulates Akt/GSK and ERK signalling pathways in OVCAR-3 ovarian cancer cells

(2012) Daniele Vergara et al.   Molecular BioSystems

Targeting Androgen Receptor to Suppress Macrophage-induced EMT and Benign Prostatic Hyperplasia (BPH) Development

(2012) Tianjing Lu et al.   MOLECULAR ENDOCRINOLOGY

The Anticancer Effects of Resveratrol: Modulation of Transcription Factors

(2012) Nichelle C. Whitlock et al.   NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL

Resveratrol Impairs the Release of Steroid-resistant Cytokines from Bacterial Endotoxin-Exposed Alveolar Macrophages in Chronic Obstructive Pulmonary Disease

(2011) Jürgen Knobloch et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Resveratrol inhibits the epidermal growth factor-induced epithelial mesenchymal transition in MCF-7 cells

(2011) Daniele Vergara et al.   CANCER LETTERS

p53 regulates epithelial–mesenchymal transition and stem cell properties through modulating miRNAs

(2011) Chun-Ju Chang et al.   NATURE CELL BIOLOGY

Resveratrol Inhibits Pancreatic Cancer Stem Cell Characteristics in Human and KrasG12D Transgenic Mice by Inhibiting Pluripotency Maintaining Factors and Epithelial-Mesenchymal Transition

(2011) Sharmila Shankar et al.   PLoS One

What Is New for an Old Molecule? Systematic Review and Recommendations on the Use of Resveratrol

(2011) Ole Vang et al.   PLoS One

Resveratrol and derivatives for the prevention and treatment of cancer

(2010) Simone Fulda   DRUG DISCOVERY TODAY

Resveratrol, sirtuins, and the promise of a DR mimetic

(2010) Joseph A. Baur   MECHANISMS OF AGEING AND DEVELOPMENT

Mechanisms of Motility in Metastasizing Cells

(2010) Mahmut Yilmaz et al.   MOLECULAR CANCER RESEARCH

Resveratrol: Its Biologic Targets and Functional Activity

(2009) Shazib Pervaiz et al.   ANTIOXIDANTS & REDOX SIGNALING

Epithelial-Mesenchymal Transitions in Development and Disease

(2009) Jean Paul Thiery et al.   CELL

Cancer chemopreventive and therapeutic potential of resveratrol: Mechanistic perspectives

(2008) Joydeb Kumar Kundu et al.   CANCER LETTERS

Resveratrol: One molecule, many targets

(2008) Luciano Pirola et al.   IUBMB LIFE